Project Grant R01MH136091
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $824,728 Project Grant under the Mental Health Research Grants program (CFDA 93.242) on March 25, 2026, with a completion date of December 31, 2030. The grant funds research to characterize intracortical feedforward and feedback sensory processes in autism spectrum disorder (ASD). The project employs a multimodal neuroimaging approach combining magnetoencephalography (MEG) with...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Boston Children's Hospital a $990,550 Project Grant (CFDA 93.242: Mental Health Research Grants) effective March 10, 2026, through February 29, 2028, to develop and test a cognitive control training intervention for school-aged children with autism spectrum disorder (ASD). The grant supports an R61/R33 phased research initiative designed to determine whether computer-based cognitive control and metacognition...
- Summary of Federal Project Grant Award The National Institute of Mental Health (NIMH) awarded the University of Maryland, Baltimore a Project Grant of $762,566 under the Mental Health Research Grants program (CFDA 93.242) effective April 1, 2026, with a completion date of December 31, 2030. This research initiative, "Quantifying Cerebellar Multi-Omic and Synaptic Features of Autism Spectrum Disorders," will generate comprehensive scientific data addressing critical knowledge gaps in...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded University of California, Los Angeles a $625,859 Project Grant effective January 27, 2026, through December 31, 2030, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research initiative aims to develop and validate objective, quantitative measures of infant motor function as predictive biomarkers for autism spectrum disorder...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $844,917 under the Mental Health Research Grants program (CFDA 93.242) for the period July 1, 2025 through April 30, 2026. This research project focuses on identifying and characterizing moderate effect size (MES) genes that contribute to autism spectrum disorder (ASD) by integrating both rare and common genetic variation. The research addresses a...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded $3.25 million to Icahn School of Medicine at Mount Sinai under the Mental Health Research Grants program (CFDA 93.242) for a research project spanning July 1, 2025, through April 30, 2030. This Project Grant funds research aimed at identifying and characterizing moderate effect size (MES) genes that contribute to Autism Spectrum Disorder (ASD) liability and manifestation. The research integrates rare and...
- Summary of Federal Grant Award The National Institute of Mental Health (NIMH) awarded a Project Grant of $175,017 to the University of Houston System on September 15, 2025, under the Mental Health Research Grants program (CFDA 93.242). The award supports a five-year research initiative (through August 31, 2030) investigating neural predictors of real-world social attention in autism during naturalistic social interactions. The project addresses a critical gap in autism research by moving...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded University of Colorado-Denver $429,000 under the Mental Health Research Grants program (CFDA 93.242) for a two-year exploratory research project spanning June 1, 2025 through May 31, 2027. The project, titled "A Synaptogenic Adhesion Code for Myelin Specificity," investigates the molecular mechanisms underlying myelin formation and white matter abnormalities associated with autism spectrum disorder (ASD)...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $129,290 on August 22, 2025, under the Mental Health Research Grants program (CFDA 93.242). This research project, extending through July 31, 2027, focuses on mapping genotype to developmental course across an autism spectrum disorder (ASD) and schizophrenia (SCZ) gradient. The Principal Investigator will analyze phenotypic, genetic, and...
- Federal Grant Award Summary Children's Hospital Los Angeles received a $769,500 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on March 15, 2026, with a completion date of March 14, 2029. This three-year research initiative focuses on developing and evaluating Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY), an autism-adapted therapeutic intervention designed to address the...
The National Institute of Mental Health (NIMH) awarded The Washington University a $811,412 Project Grant (CFDA 93.242: Mental Health Research Grants) effective May 1, 2026, through February 28, 2031, to establish the specificity and scalability of motor imitation assessments as a biomarker for Autism Spectrum Disorder (ASD). The research combines innovative wearable high-density diffuse optical tomography (HD-DOT) functional neuroimaging with a computerized assessment of motor imitation (CAMI) to advance diagnostic differentiation of ASD from related neurodevelopmental conditions such as attention-deficit/hyperactivity disorder and developmental language disorder. The primary deliverables include validation of the CAMI's diagnostic discrimination capability, evidence regarding the specificity of imitation deficits as they distinguish ASD from overlapping conditions, and documentation of the assessment's scalability for deployment in clinical and home settings. This research addresses a critical public health need, as ASD affects approximately 1 in 36 children in the United States at an estimated annual cost of $37 billion. By establishing the neurobiological mechanisms underlying imitation deficits and demonstrating the clinical utility of automated assessments, the project aims to reduce diagnostic delays and improve clinical care planning for autistic children with complex presentations and multiple comorbidities. Anticipated products include peer-reviewed publications, datasets, and refined assessment protocols that can be readily implemented across diverse clinical settings.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $811.4k | 5/5/26 |